The effect of lixisenatide in type 1 diabetes: a randomised controlled trial
Latest Information Update: 18 Mar 2019
At a glance
- Drugs Lixisenatide (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms LIXI
- 05 Oct 2018 Results presented at the 54th Annual Meeting of the European Association for the Study of Diabetes
- 24 Feb 2016 Accrual to date is 87% according to United Kingdom Clinical Research Network record
- 24 Feb 2016 Status changed from recruiting to active, no longer recruiting according to United Kingdom Clinical Research Network record.